Sanofi-Aventis Receives Pediatric Exclusivity For Ambien® And Ambien® CR
Sanofi-aventis announced today that the U.S. Foodand Drug Administration (FDA) has granted pediatric exclusivity for Ambien® (zolpidemtartrate) and Ambien® CR (zolpidem tartrate extended-release). [click link for full article]
posted by Smile Community @ 12:06 AM
0 Comments:
Post a Comment
<< Home